author-photo

Rosina Paterra

22

Papers

288

Citations

Citation Trend

Filter By

Papers (17) Sort By

Journal Conference Others

TEM-GBM: An Open-Label, Phase I/IIa Dose-Escalation Study Evaluating the Safety and Efficacy of Genetically Modified Tie-2 Expressing Monocytes to Deliver IFN-α within Glioblastoma Tumor Microenvironment

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
IMMU-01. TEM-GBM: AN OPEN-LABEL, PHASE I/IIA DOSE-ESCALATION STUDY EVALUATING THE SAFETY AND EFFICACY OF GENETICALLY MODIFIED TIE-2 EXPRESSING MONOCYTES TO DELIVER IFN-A WITHIN GLIOBLASTOMA TUMOR MICROENVIRONMENT

2021
Show All
- Source
- Cite
- Save
Citations (0)
CTIM-19. TEM-GBM: A PHASE I-IIA DOSE-ESCALATION STUDY DELIVERING IFN-Α WITHIN GLIOBLASTOMA MULTIFORME TUMOR MICROENVIRONMENT BY GENETICALLY MODIFIED TIE-2 EXPRESSING MONOCYTES

2021 Neuro-oncology
Show All
- Source
- Cite
- Save
Citations (0)
Gliomatosis cerebri (GC) or GC-like? A picture to be reconsidered in neuro-oncology based on large retrospective analysis of GC series

2020 Neurological Sciences
Show All
- Source
- Cite
- Save
Citations (0)
High tumor mutational burden and T-cell activation are associated with long-term response to anti-PD1 therapy in Lynch syndrome recurrent glioblastoma patient.

2020 Cancer Immunology, Immunotherapy
Show All
- Source
- Cite
- Save
Citations (7)
CTIM-24. AUTOLOGOUS CD34+ ENRICHED HEMATOPOIETIC PROGENITOR CELLS GENETICALLY MODIFIED FOR HUMAN INTERFERON-α2, ARE WELL TOLERATED & RAPIDLY ENGRAFT IN PATIENTS WITH GLIOBLASTOMA MULTIFORME (TEM-GBM_001 STUDY)

2020 Neuro-oncology
Show All
- Source
- Cite
- Save
Citations (1)
Simultaneous Detection of NF1, SPRED1, LZTR1, and NF2 Gene Mutations by Targeted NGS in an Italian Cohort of Suspected NF1 Patients.

2020 Genes
Show All
- Source
- Cite
- Save
Citations (1)
ABCC3 Expressed by CD56dim CD16+ NK Cells Predicts Response in Glioblastoma Patients Treated with Combined Chemotherapy and Dendritic Cell Immunotherapy

2019 International Journal of Molecular Sciences
Show All
- Source
- Cite
- Save
Citations (9)
OS9.3 Clinical, molecular and radiomic profile of gliomas with FGFR3-TACC3 fusion

2019 Neuro-oncology
Show All
- Source
- Cite
- Save
Citations (10)
In vivo 2-hydroxyglutarate-proton magnetic resonance spectroscopy (3 T, PRESS technique) in treatment-naïve suspect lower-grade gliomas: feasibility and accuracy in a clinical setting

2019 Neurological Sciences
Show All
- Source
- Cite
- Save
Citations (4)